• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于整合转录组学鉴定卵巢癌细胞中紫杉醇耐药基因的隐匿驱动因素:雄激素受体分析

Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor.

作者信息

Sun Nian-Kang, Huang Shang-Lang, Lu Hsing-Pang, Chang Ting-Chang, Chao Chuck C-K

机构信息

Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China.

Division of Biomedical Sciences, Chang Gung University of Science and Technology, Taoyuan, Taiwan, Republic of China.

出版信息

Oncotarget. 2015 Sep 29;6(29):27065-82. doi: 10.18632/oncotarget.4824.

DOI:10.18632/oncotarget.4824
PMID:26318424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4694974/
Abstract

A systematic analysis of the genes involved in taxol resistance (txr) has never been performed. In the present study, we created txr ovarian carcinoma cell lines to identify the genes involved in chemoresistance. Transcriptome analysis revealed 1,194 overexpressed genes in txr cells. Among the upregulated genes, more than 12 cryptic transcription factors were identified using MetaCore analysis (including AR, C/EBPβ, ERα, HNF4α, c-Jun/AP-1, c-Myc, and SP-1). Notably, individual silencing of these transcription factors (except HNF4`)sensitized txr cells to taxol. The androgen receptor (AR) and its target genes were selected for further analysis. Silencing AR using RNA interference produced a 3-fold sensitization to taxol in txr cells, a response similar to that produced by silencing abcb1. AR silencing also downregulated the expression of prominent txr gene candidates (including abcb1, abcb6, abcg2, bmp5, fat3, fgfr2, h1f0, srcrb4d, and tmprss15). In contrast, AR activation using the agonist DHT upregulated expression of the target genes. Individually silencing seven out of nine (78%) AR-regulated txr genes sensitized txr cells to taxol. Inhibition of AKT and JNK cellular kinases using chemical inhibitors caused a dramatic suppression of AR expression. These results indicate that the AR represents a critical driver of gene expression involved in txr.

摘要

从未对参与紫杉醇耐药性(txr)的基因进行过系统分析。在本研究中,我们创建了txr卵巢癌细胞系以鉴定参与化疗耐药性的基因。转录组分析揭示了txr细胞中有1194个过表达基因。在这些上调基因中,使用MetaCore分析鉴定出12种以上潜在转录因子(包括AR、C/EBPβ、ERα、HNF4α、c-Jun/AP-1、c-Myc和SP-1)。值得注意的是,单独沉默这些转录因子(HNF4`除外)可使txr细胞对紫杉醇敏感。选择雄激素受体(AR)及其靶基因进行进一步分析。使用RNA干扰沉默AR可使txr细胞对紫杉醇的敏感性提高3倍,这一反应与沉默abcb1所产生的反应相似。AR沉默还下调了主要txr基因候选物(包括abcb1、abcb6、abcg2、bmp5、fat3、fgfr2、h1f0、srcrb4d和tmprss15)的表达。相反,使用激动剂双氢睾酮激活AR可上调靶基因的表达。单独沉默9个AR调控的txr基因中的7个(78%)可使txr细胞对紫杉醇敏感。使用化学抑制剂抑制AKT和JNK细胞激酶可显著抑制AR表达。这些结果表明,AR是参与txr的基因表达的关键驱动因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/b44c960db5f8/oncotarget-06-27065-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/b22aa85d7e01/oncotarget-06-27065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/27cdea290ee5/oncotarget-06-27065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/32ebeeeeb622/oncotarget-06-27065-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/23c5c94de9aa/oncotarget-06-27065-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/fe566a15abaa/oncotarget-06-27065-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/494111945f0c/oncotarget-06-27065-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/b44c960db5f8/oncotarget-06-27065-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/b22aa85d7e01/oncotarget-06-27065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/27cdea290ee5/oncotarget-06-27065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/32ebeeeeb622/oncotarget-06-27065-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/23c5c94de9aa/oncotarget-06-27065-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/fe566a15abaa/oncotarget-06-27065-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/494111945f0c/oncotarget-06-27065-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/4694974/b44c960db5f8/oncotarget-06-27065-g007.jpg

相似文献

1
Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor.基于整合转录组学鉴定卵巢癌细胞中紫杉醇耐药基因的隐匿驱动因素:雄激素受体分析
Oncotarget. 2015 Sep 29;6(29):27065-82. doi: 10.18632/oncotarget.4824.
2
Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response.紫杉醇耐药卵巢癌细胞的转录组分析确定FKBP5和雄激素受体是化疗反应的关键标志物。
Oncotarget. 2014 Dec 15;5(23):11939-56. doi: 10.18632/oncotarget.2654.
3
Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells.雄激素受体转录活性和 ABCB1/MDR 基因的染色质修饰对于卵巢癌细胞的紫杉醇耐药性至关重要。
J Cell Physiol. 2019 Jun;234(6):8760-8775. doi: 10.1002/jcp.27535. Epub 2018 Oct 14.
4
H1.0 induces paclitaxel-resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor.H1.0 通过招募 GCN5 和雄激素受体诱导卵巢癌细胞中紫杉醇耐药基因的表达。
Cancer Sci. 2022 Aug;113(8):2616-2626. doi: 10.1111/cas.15448. Epub 2022 Jun 13.
5
TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells.Toll样受体4(TLR4)和核因子κB(NFκB)信号传导对卵巢癌细胞的紫杉醇耐药性至关重要。
J Cell Physiol. 2018 Mar;233(3):2489-2501. doi: 10.1002/jcp.26125. Epub 2017 Aug 30.
6
Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cells.TLR4-雄激素受体轴和金雀异黄素在紫杉醇耐药卵巢癌细胞中的作用。
Biochem Pharmacol. 2020 Jul;177:113965. doi: 10.1016/j.bcp.2020.113965. Epub 2020 Apr 9.
7
TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer.TLR4/IL-6/IRF1 信号通路调控雄激素受体表达:克服卵巢癌紫杉醇耐药的潜在治疗靶点。
Biochem Pharmacol. 2021 Apr;186:114456. doi: 10.1016/j.bcp.2021.114456. Epub 2021 Feb 6.
8
The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.两种耐紫杉醇前列腺癌细胞系的建立及两种细胞系的紫杉醇耐药机制
Prostate. 2007 Jun 15;67(9):955-67. doi: 10.1002/pros.20581.
9
Gene expression profiling of taxol-resistant nasopharyngeal carcinoma cells with siRNA-mediated FOLR1 downregulation.采用小干扰RNA介导的叶酸受体1(FOLR1)下调对耐紫杉醇鼻咽癌细胞进行基因表达谱分析。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11314-22. eCollection 2015.
10
Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity.姜黄素通过上调 SNIP1 并抑制 NFκB 活性降低卵巢癌细胞对紫杉醇的耐药性。
Biochem Pharmacol. 2023 Jun;212:115581. doi: 10.1016/j.bcp.2023.115581. Epub 2023 May 4.

引用本文的文献

1
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities.非前列腺恶性肿瘤中的雄激素受体信号传导:挑战与机遇
Nat Rev Cancer. 2025 Feb;25(2):93-108. doi: 10.1038/s41568-024-00772-w. Epub 2024 Nov 25.
2
Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics.卵巢癌中的核受体:癌症治疗范式的转变
Front Oncol. 2024 Jul 15;14:1383939. doi: 10.3389/fonc.2024.1383939. eCollection 2024.
3
Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors.

本文引用的文献

1
Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response.紫杉醇耐药卵巢癌细胞的转录组分析确定FKBP5和雄激素受体是化疗反应的关键标志物。
Oncotarget. 2014 Dec 15;5(23):11939-56. doi: 10.18632/oncotarget.2654.
2
Maintaining and reprogramming genomic androgen receptor activity in prostate cancer.维持和重新编程前列腺癌中的基因组雄激素受体活性。
Nat Rev Cancer. 2014 Mar;14(3):187-98. doi: 10.1038/nrc3678.
3
Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo.
卵巢癌化疗耐药性发展中的新参与者:卵巢癌干细胞、非编码RNA和核受体。
Cancer Drug Resist. 2024 Feb 28;7:6. doi: 10.20517/cdr.2023.152. eCollection 2024.
4
Molecular Regulation of Androgen Receptors in Major Female Reproductive System Cancers.雄激素受体在女性主要生殖系统癌症中的分子调控。
Int J Mol Sci. 2022 Jul 8;23(14):7556. doi: 10.3390/ijms23147556.
5
H1.0 induces paclitaxel-resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor.H1.0 通过招募 GCN5 和雄激素受体诱导卵巢癌细胞中紫杉醇耐药基因的表达。
Cancer Sci. 2022 Aug;113(8):2616-2626. doi: 10.1111/cas.15448. Epub 2022 Jun 13.
6
Multidrug efflux transporter ABCG2: expression and regulation.多药外排转运蛋白 ABCG2:表达与调控。
Cell Mol Life Sci. 2021 Nov;78(21-22):6887-6939. doi: 10.1007/s00018-021-03901-y. Epub 2021 Sep 29.
7
Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).卵巢癌的激素治疗:强调机制与应用(综述)。
Oncol Rep. 2021 Oct;46(4). doi: 10.3892/or.2021.8174. Epub 2021 Aug 26.
8
Novel compound variants of the AR and MAP3K1 genes are related to the clinical heterogeneity of androgen insensitivity syndrome.新型 AR 和 MAP3K1 基因突变与雄激素不敏感综合征的临床异质性相关。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20200616.
9
A Multi-Omics Analysis of Bone Morphogenetic Protein 5 ( Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches.使用生物信息学方法对骨形态发生蛋白5在不同癌症中的表达及临床预后结果进行的多组学分析。
Biomedicines. 2020 Jan 21;8(2):19. doi: 10.3390/biomedicines8020019.
10
Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis.通过消融雄激素受体/芳烃受体-ABCG2轴提高紫杉醇敏感性以更好地抑制浆液性上皮性卵巢癌
Cancers (Basel). 2019 Apr 2;11(4):463. doi: 10.3390/cancers11040463.
雄激素受体在体内使用宽松的反应元件严谨性进行选择性染色质结合和转录调控。
Nucleic Acids Res. 2014 Apr;42(7):4230-40. doi: 10.1093/nar/gkt1401. Epub 2014 Jan 22.
4
Castration-resistant prostate cancer: adaptive responses in the androgen axis.去势抵抗性前列腺癌:雄激素轴中的适应性反应。
Cancer Treat Rev. 2014 Apr;40(3):426-33. doi: 10.1016/j.ctrv.2013.09.011. Epub 2013 Sep 14.
5
Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.Jak2 抑制剂 AZD1480 通过抑制 Jak2-Stat5 信号通路强烈抑制原发和去势抵抗性前列腺癌的生长。
Clin Cancer Res. 2013 Oct 15;19(20):5658-74. doi: 10.1158/1078-0432.CCR-13-0422. Epub 2013 Aug 13.
6
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.雄激素受体通过上调 c-Myc 促进配体非依赖性前列腺癌的进展。
PLoS One. 2013 May 21;8(5):e63563. doi: 10.1371/journal.pone.0063563. Print 2013.
7
Amplitude modulation of androgen signaling by c-MYC.c-MYC 对雄激素信号的幅度调制。
Genes Dev. 2013 Apr 1;27(7):734-48. doi: 10.1101/gad.209569.112. Epub 2013 Mar 25.
8
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.雄激素受体在人类去势抵抗性前列腺癌中诱导了一个独特的转录程序。
Cancer Cell. 2013 Jan 14;23(1):35-47. doi: 10.1016/j.ccr.2012.11.010. Epub 2012 Dec 20.
9
Hormone response in ovarian cancer: time to reconsider as a clinical target?卵巢癌中的激素反应:是否应重新考虑将其作为临床靶点?
Endocr Relat Cancer. 2012 Nov 9;19(6):R255-79. doi: 10.1530/ERC-12-0175. Print 2012 Dec.
10
Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.乳腺癌中的紫杉烷类耐药性:机制、预测生物标志物和规避策略。
Cancer Treat Rev. 2012 Nov;38(7):890-903. doi: 10.1016/j.ctrv.2012.02.011. Epub 2012 Mar 31.